BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1428083)

  • 1. Peroxisome proliferation and hepatocarcinogenesis.
    Reddy JK; Rao MS
    IARC Sci Publ; 1992; (116):225-35. PubMed ID: 1428083
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell proliferation and promotion in the hepatocarcinogenicity of peroxisome proliferating chemicals.
    Cattley RC; Marsman DS; Popp JA
    Prog Clin Biol Res; 1990; 340D():123-32. PubMed ID: 2196574
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peroxisome proliferation and possible cancer hazard].
    Dybing E; Sanner T
    Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Drug Metab Rev; 1989; 21(1):103-10. PubMed ID: 2696631
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocarcinogenesis of peroxisome proliferators.
    Rao MS; Reddy JK
    Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
    [No Abstract]   [Full Text] [Related]  

  • 6. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
    Cattley RC; Miller RT; Corton JC
    Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroxisome proliferators and hepatocarcinogenesis].
    Tamura H
    Seikagaku; 1995 Aug; 67(8):1044-7. PubMed ID: 7594872
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis.
    Popp JA; Cattley RC; Miller RT; Marsman DS
    Prog Clin Biol Res; 1994; 387():193-207. PubMed ID: 7972246
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat.
    Columbano A; Ledda-Columbano GM; Coni P; Pichiri-Coni G; Curto M; Pani P
    Prog Clin Biol Res; 1991; 369():217-25. PubMed ID: 1946520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.
    Moody DE; Gibson GG; Grant DF; Magdalou J; Rao MS
    Drug Metab Dispos; 1992; 20(6):779-91. PubMed ID: 1362927
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens.
    Williams GM; Perrone C
    Ann N Y Acad Sci; 1996 Dec; 804():554-72. PubMed ID: 8993573
    [No Abstract]   [Full Text] [Related]  

  • 14. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
    Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
    Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver.
    Cunningham ML; Soliman MS; Badr MZ; Matthews HB
    Cancer Lett; 1995 Aug; 95(1-2):93-7. PubMed ID: 7656250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
    Rao MS; Lalwani ND; Watanabe TK; Reddy JK
    Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response.
    Bannasch P; Zerban H
    IARC Sci Publ; 1992; (116):389-427. PubMed ID: 1428091
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds.
    Schulte-Hermann R; Bursch W; Parzefall W
    Prog Clin Biol Res; 1991; 369():237-44. PubMed ID: 1946522
    [No Abstract]   [Full Text] [Related]  

  • 19. Environmental chemicals in hepatocarcinogenesis: the mechanism of tumor promoters.
    Schwarz LR; Greim H
    Prog Liver Dis; 1986; 8():581-95. PubMed ID: 3012642
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.